Hans G. Klingemann,Laurent H. Boissel,Abhijit Dandapat
申请号：
US16529159
公开号：
US20200129552A1
申请日:
2019.08.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are compositions of NK-92™； cells that express a combination of PD-L1 CAR, CD16 and IL2, and the method of using these cells to reduce tumor cells and cells in tumor microenvironment (e.g., MDSCs or TAMs) and treat cancer.
